Imagyn instruments get US clearance:
This article was originally published in Clinica
Executive Summary
Imagyn Medical Technologies has received FDA 510(k) clearance to market its Pivotal line of articulating instruments for minimally-invasive surgery. The instruments, which include scissors, dissectors, graspers and coagulation instruments, pivot at the tip. This enables surgeons to manoeuvre them more easily through small incisions, therefore allowing access to all areas of the anatomy. The company said that the instruments would be used in operations involving laparoscopic techniques such as minimally invasive cardiac surgery, lung resection and spinal, orthopaedic and plastic surgery procedures.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.